Tolou Ghamari Z, Mazdak H
Isfahan Kidney Transplantation Research Center.
Department of Urology, Isfahan University of Medical Sciences. Isfahan, Iran.
Urologiia. 2019 Dec 31(6):74-77.
The aim of this study was to clarify period prevalence (PP) and incidence associated to urinary system cancers in Isfahan Province/Iran.
s: Data from 2011 to 2015 was obtained from the Isfahan Cancer Registry. The location of cancers was distinguished by the related established topography code (C64-C68). Period prevalence (PP) was calculated and expressed per 100000 persons.
There were 2117 patients with urinary system cancers. The mean age +/- SD was 63.6+/-14.9 years old, that in 62% ranged between 20 and 70 years old. For total population the PP was calculated as 42. 5 per 100000 persons. This value was corresponded to PP of 66.4 for males and 17.9 for females (p<0.001). The total PP was corresponded to values of 33.2 for bladder, 8.1 for kidney, 0.42 for renal pelvis, 0.36 for ureter and 0.38 for other unspecified related organs. Of these populations the estimated living cases corresponded to the 368 females and 1513 males.
The PP for urinary system cancers in male population was 3.7 times higher than females. There was a 23.2% increase in the Irs over the study period. These findings highlighted the advantage of further strategy base-research toward pharmacotherapy and surgery management of such patients.
本研究旨在明确伊朗伊斯法罕省泌尿系统癌症的期间患病率(PP)及发病率。
从伊斯法罕癌症登记处获取2011年至2015年的数据。癌症位置通过相关的既定地形代码(C64 - C68)区分。计算期间患病率(PP)并以每100000人表示。
有2117例泌尿系统癌症患者。平均年龄±标准差为63.6±14.9岁,其中62%在20至70岁之间。总人口的PP计算为每100000人42.5。该值对应男性PP为66.4,女性为17.9(p<0.001)。总PP对应膀胱为33.2、肾脏为8.1、肾盂为0.42、输尿管为0.36、其他未指定相关器官为0.38。在这些人群中,估计存活病例为368名女性和1513名男性。
男性人群泌尿系统癌症的PP比女性高3.7倍。研究期间Irs增加了23.2%。这些发现突出了针对此类患者药物治疗和手术管理进一步开展基于策略的研究的优势。